StonvexLoading…
StonvexStonvexStonvexCore line items from INBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.07M | $2.01M | $1.11M | $3.05M |
Operating Income | $-8.64M | $-5.64M | $-3.00M | $-10.64M |
Net Income | $-8.52M | $-5.66M | $-2.98M | $-10.57M |
EPS (Diluted) | $-7.54 | $-6.27 | $-0.35 | $-2.00 |
Total Assets | $14.86M | $17.65M | $10.04M | $8.25M |
Total Liabilities | $6.11M | $6.76M | $6.61M | $5.44M |
Cash & Equivalents | $6.86M | $740.37K | $1.66M | $1.02M |
Free Cash Flow OCF − CapEx | $-8.87M | $-4.55M | $-2.92M | $-9.91M |
Shares Outstanding | 2.00M | 1.24M | 9.10M | 732.33K |